These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Modulation of (-)-sulpiride-induced increase in electrically-evoked release of dopamine from rat striatal slices.
    Author: Yamada S, Yokoo H, Nishi S.
    Journal: J Pharm Pharmacol; 1993 May; 45(5):479-81. PubMed ID: 8099971.
    Abstract:
    (-)-Sulpiride (10 nM-10 microM) in the superfusate, dose-dependently increased the electrically-evoked release of dopamine from rat striatal slices. (+)-Sulpiride had little effect on evoked release of dopamine up to 10 microM. Apomorphine inhibited electrically evoked release of dopamine, and this effect of apomorphine was antagonized by (-)-sulpiride. SCH23390 and forskolin had no effect on the (-)-sulpiride-induced increase in evoked release of dopamine. Treatment with the irreversible dopamine-receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline caused a significant increase in evoked release of dopamine and prevented the (-)-sulpiride-induced increase in the evoked release of dopamine. These results indicate that the (-)-sulpiride-induced increase in evoked release of dopamine is due to antagonism of the activation of dopamine autoreceptors by endogenously released dopamine.
    [Abstract] [Full Text] [Related] [New Search]